Abstract:
The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds modulate the activity of farnesoid X receptor (FXR), for example, as agonists. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with FXR dysregulation, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.
Applicants
1. BRISTOL-MYERS SQUIBB COMPANY
Route 206 and Province Line Road
Princeton, New Jersey 08543
Inventors
1. YOON, David S.
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
2. ANUMULA, Rushith Kumar
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
3. CHERUKU, Srinivas
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
4. HUANG, Yanting
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
5. JURICA, Elizabeth Anne
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
6. MENG, Wei
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
7. NARA, Susheel Jethanand
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
8. NARAYAN, Rishikesh
c/o Goa Engineering College (GEC) Campus
Farmagudi Ponda 403401
Goa
9. SISTLA, Ramesh Kumar
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
10. WU, Ximao
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
11. ZHAO, Guohua
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
Specification
1. YOON, David S.
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
2. ANUMULA, Rushith Kumar
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
3. CHERUKU, Srinivas
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
4. HUANG, Yanting
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
5. JURICA, Elizabeth Anne
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
6. MENG, Wei
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
7. NARA, Susheel Jethanand
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
8. NARAYAN, Rishikesh
c/o Goa Engineering College (GEC) Campus
Farmagudi Ponda 403401
Goa
9. SISTLA, Ramesh Kumar
c/o Syngene International Limited, Biocon Special Economic Zone
Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area IV Phase
Jigani Link Road, Bommasandra, Bangalore 560 099
Karnataka
10. WU, Ximao
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
11. ZHAO, Guohua
c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543
Specification
Documents
Documents
Name
Date
1
202017022199-AbandonedLetter.pdf
2024-02-19
2
202017022199-Correspondence-230522.pdf
2022-05-30
3
202017022199-Others-230522.pdf
2022-05-30
4
202017022199-Proof of Right [09-05-2022(online)].pdf